What is NeoGenomics's long-term debt?

NeoGenomics (NEO) reported long-term debt of $374.24M in Q2 2026.

What does long-term debt mean?

Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

NeoGenomics NEO Long-Term Debt

Long-Term Debt at other companies

Myriad GeneticsMYGN

$120.3M+103%

Labcorp HoldingsLH

$5.86B+15.4%

Quest DiagnosticsDGX

$5.63B+9.0%

Biodesix, Inc.BDSX

$46.49M+26.7%

GeneDx HoldingsWGS

$96.73M+86.8%

Guardant HealthGH

——

Other financials

Income statement

See full

Revenue$201.7M+11.2%

Gross profit$91.9M+18.9%

Operating income-$9.8M+79.5%

Net income$2.2M+105%

EPS (diluted)$0.02+106%

Balance sheet

See full

Cash & equivalents$145.5M-5.9%

Total debt$448.4M+534%

Total equity$785.7M-8.0%

Total assets$1.4B-3.0%

Cash flow

See full

Operating cash flow$20.0M-1.8%

CapEx$8.2M+30.0%

Free cash flow-$13.1M+56.0%

Valuation

See full

Market cap$1.74B+158%

Enterprise value$2.05B+246%

P/S2.3×+1.3×

Profitability

See full

Gross margin43.9%0.0pp

Operating margin-8.9%-2.8pp

Net margin-6.8%-2.4pp

FCF margin-4.9%—

Returns & leverage

See full

Return on equity-6.3%-2.0pp

Debt / equity0.6×+0.5×

Current ratio3.6×-0.3×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: NeoGenomics’s 10-Q, filed July 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NeoGenomics's long-term debt?: NeoGenomics (NEO) reported long-term debt of $374.24M in Q2 2026.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.